Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer ...

Nam Quoc Bui, MD, discusses survival, symptom control, and ovarian toxicity in the DeFi trial of nirogacestat in patients ...

The results of the DeFi trial of nirogacestat in 142 adults with progressing desmoid tumours showed a significant 71% improvement with the drug on progression-free survival (PFS) compared to ...

In a continuation of its awareness and education efforts around desmoid tumors, SpringWorks Therapeutics has partnered with celebrity jewelry designer and patient advocate Jennifer Fisher. Just over ...

SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...

Shares of SpringWorks Therapeutics SWTX have rallied 32.9% in the past three months compared with the industry’s increase of ...

A teenage cricket star who survived three rounds of chemotherapy and still carries a tumour which affects his batting has ...

AlphaQuest LLC grew its stake in shares of Immunome, Inc. (NASDAQ:IMNM – Free Report) by 786,700.0% during the 4th quarter, ...

StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the stock.

A Grinnell couple’s dream to help other families after they lost their son to a rare disease took a big step forward at Iowa ...